2019-2-13 12:00 |
Pharma giant Boehringer Ingelheim is set to trial IBM blockchain in Canada to raise the quality of processes and records in clinical trials. origin »
|
Pharma giant Boehringer Ingelheim is set to trial IBM blockchain in Canada to raise the quality of processes and records in clinical trials.
2019-2-13 12:00 | |
|
|
The counterfeit business is thriving, while genuine businesses are suffering greatly. According to one report, counterfeit goods cost the global economy an estimated $323 billion in 2018. As stated by Forbes, counterfeiting is the world’s largest illegal industry. By 2022,…
Pharma giant Boehringer Ingelheim is set to trial IBM blockchain in Canada to raise the quality of processes and records in clinical trials.
The blockchain has very exciting implications for the Pharmaceutical industry. By creating a space for super advanced audit trails, identification and authentication, the blockchain promises to totally re-shape the way medicines are stored and delivered to patients across the world.
Following China's pharma scandal, investors are buying into a firm's claim to be developing a vaccine-tracking blockchain, but not everyone is happy.